Yousif Capital Management LLC Decreases Stock Holdings in Colgate-Palmolive Company $CL

Yousif Capital Management LLC trimmed its holdings in shares of Colgate-Palmolive Company (NYSE:CL) by 3.7% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 191,126 shares of the company’s stock after selling 7,371 shares during the quarter. Yousif Capital Management LLC’s holdings in Colgate-Palmolive were worth $17,373,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently modified their holdings of CL. Westend Capital Management LLC increased its position in shares of Colgate-Palmolive by 111.1% during the first quarter. Westend Capital Management LLC now owns 266 shares of the company’s stock valued at $25,000 after acquiring an additional 140 shares during the last quarter. Cornerstone Planning Group LLC increased its position in shares of Colgate-Palmolive by 1,913.3% during the first quarter. Cornerstone Planning Group LLC now owns 302 shares of the company’s stock valued at $28,000 after acquiring an additional 287 shares during the last quarter. Saudi Central Bank purchased a new stake in shares of Colgate-Palmolive during the first quarter valued at approximately $29,000. Ransom Advisory Ltd bought a new position in Colgate-Palmolive during the first quarter valued at $33,000. Finally, Harel Insurance Investments & Financial Services Ltd. bought a new position in Colgate-Palmolive during the first quarter valued at $37,000. 80.41% of the stock is owned by hedge funds and other institutional investors.

Colgate-Palmolive Price Performance

Colgate-Palmolive stock opened at $77.99 on Monday. Colgate-Palmolive Company has a one year low of $77.09 and a one year high of $102.61. The business has a fifty day moving average price of $82.56 and a 200-day moving average price of $87.84. The company has a debt-to-equity ratio of 6.79, a current ratio of 0.89 and a quick ratio of 0.57. The firm has a market capitalization of $63.03 billion, a P/E ratio of 21.91, a PEG ratio of 4.29 and a beta of 0.34.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings results on Friday, August 1st. The company reported $0.92 EPS for the quarter, topping analysts’ consensus estimates of $0.89 by $0.03. Colgate-Palmolive had a return on equity of 377.63% and a net margin of 14.55%.The firm had revenue of $5.11 billion during the quarter, compared to analyst estimates of $5.03 billion. During the same period last year, the company earned $0.91 earnings per share. The business’s revenue for the quarter was up 1.0% on a year-over-year basis. As a group, equities research analysts forecast that Colgate-Palmolive Company will post 3.75 EPS for the current year.

Colgate-Palmolive Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, November 14th. Investors of record on Friday, October 17th will be given a $0.52 dividend. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.7%. The ex-dividend date is Friday, October 17th. Colgate-Palmolive’s dividend payout ratio (DPR) is 58.43%.

Analysts Set New Price Targets

Several brokerages have weighed in on CL. The Goldman Sachs Group reduced their price objective on Colgate-Palmolive from $106.00 to $91.00 and set a “buy” rating for the company in a report on Thursday, October 2nd. Bank of America reduced their price objective on Colgate-Palmolive from $98.00 to $88.00 and set a “buy” rating for the company in a report on Wednesday, October 8th. UBS Group reduced their price objective on Colgate-Palmolive from $99.00 to $92.00 and set a “buy” rating for the company in a report on Wednesday. Barclays reduced their price objective on Colgate-Palmolive from $87.00 to $82.00 and set an “equal weight” rating for the company in a report on Wednesday, October 1st. Finally, Wells Fargo & Company reduced their price objective on Colgate-Palmolive from $83.00 to $80.00 and set an “underweight” rating for the company in a report on Thursday, September 25th. Eight equities research analysts have rated the stock with a Buy rating, five have given a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $92.21.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.